yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q37058114-3A7166D5-E8CB-4231-966D-60BD146FE270
Q37058114-3A7166D5-E8CB-4231-966D-60BD146FE270
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37058114-3A7166D5-E8CB-4231-966D-60BD146FE270
CHAMPION-1: a phase 1/2 study of once-weekly carfilzomib and dexamethasone for relapsed or refractory multiple myeloma.
P433
Q37058114-3A7166D5-E8CB-4231-966D-60BD146FE270
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37058114-3A7166D5-E8CB-4231-966D-60BD146FE270
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a0129374fcdcc53efb6dfff448951a72f6f21f4f
P433
26
http://www.w3.org/2001/XMLSchema#string